Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Names Drug Safety Board Members; First Meeting In Early Summer

This article was originally published in The Tan Sheet

Executive Summary

Department of Veterans Affairs pharmacy benefit management advisor Chester Good brings experience with drug-related adverse event reporting to FDA's Drug Safety Oversight Board

You may also be interested in...



Drug Safety Board Is Biased By Connection To CDER, Sen. Grassley Says

Sen. Charles Grassley (R-Iowa) is asking FDA to outline what actions the agency will take to ensure that the Drug Safety Oversight Board is "objective.

Drug Safety Board Is Biased By Connection To CDER, Sen. Grassley Says

Sen. Charles Grassley (R-Iowa) is asking FDA to outline what actions the agency will take to ensure that the Drug Safety Oversight Board is "objective.

Drug Safety Board Is Biased By Connection To CDER, Sen. Grassley Says

Sen. Charles Grassley (R-Iowa) is asking FDA to outline what actions the agency will take to ensure that the Drug Safety Oversight Board is "objective.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098254

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel